Immune thrombocytopenia can be a recognised complication of CLL due to our dysregulated immune system. This abstract reports that COVID-19 vaccination may adversely affect immune thrombocytopenia (ITP) patients although it does not specifically mention CLL ITP patients.
52 consecutive chronic ITP patients were prospectively followed after COVID-19 vaccination. 15% had no worsening of clinical symptoms but no post-vaccination platelet count; 73% had no new symptoms and no platelet count decline. However, 12% had a median platelet count drop of 96% within 2-5 days post-vaccination with new bleeding symptoms; after rescue therapy with corticosteroids +/-IVIG, platelets recovered to >30x109 /L a median 3 days later.
ITP exacerbation occurred independent of ITP remission status, concurrent ITP treatment, vaccine type. Safety of a second vaccine dose needs careful assessment.
Reference here: pubmed.ncbi.nlm.nih.gov/340...
If you have ITP with your CLL please discuss monitoring your platelet count with your doctor in the days following your vaccination.
Jackie